By 
The Power of 3-7-11 and the Grand Super Cycle: How We Saw the Bullish Turn in April 2025 Back on April 9, 2025, while World Indices were dropping sharply and global sentiment had turned overwhelmingly bearish, we published an article that challenged the fear-driven narrative. We explained why selling was not the right approach and […]
-
SuperVerse Initiating The Elliott Wave SUPER Rally
Read MoreSuperVerse SUPER is building the Web3 infrastructure for Gaming and expected to be one of the leading pioneers in the industry. In this article, we’ll explore the potential bullish Elliott Wave path. SUPER initially rallied within an impulsive 5 waves advance since October 2023 and it ended wave ((1)) at $1.6 on March 2024. The token did […]
-
Gold-to-Silver Ratio (AUG) Can be in Triangle Consolidation
Read MoreGold-to-Silver Ratio (AUG) is a ratio of the underlying metals (i.e. Gold and Silver). The ratio is simply calculated by dividing Gold price and Silver price, thus the name Gold to Silver ratio. Since the 1970s, after the gold standard was abandoned, the long-run average gold-to-silver ratio is around 65:1. Over the past 50 years, […]
-
Elliott Wave View: Tesla (TSLA) Impulsive Rally Remains in Progress
Read MoreTesla (TSLA) impulsive rally is in progress and the stock should extend higher. This article and video look at the Elliott Wave path.
-
Biotech ETF (XBI) Ended a Diagonal. Looking for Buying Dips.
Read MoreThe SPDR S&P Biotech ETF (XBI) is an exchange-traded fund that tracks the biotechnology segment of the S&P Total Market Index. This ETF allows investors to gain exposure to large, mid, and small-cap biotech stocks. If you’re interested in biotechnology, XBI could be worth exploring further. Here are some of its top holdings and their percentage weights: United Therapeutics […]